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Abstract
Purpose: To test the effect of body composition, cardiorespiratory fitness, and physical activity
levels on serum gamma-glutamyltransferase (GGT) among college students who consume
alcohol. Methods: Seven male and nine female subjects over 21 years old completed the Alcohol
Use Disorders Identification (AUDIT), a maximal treadmill test to measure maximal oxygen
uptake (VO2max), a DEXA scan for body fat percentage, and a venous blood draw for serum
GGT. In addition, subjects were assessed with respect to average daily moderate-to-vigorous
physical activity (MVPA) via continuously worn (while awake) accelerometer for one week.
Subjects were grouped based on AUDIT scores [ > 8= high alcohol intake (n = 9); < 8 = low
alcohol intake (n = 7)] and compared with respect to outcome variables using a series of
independent t-test. Correlations between serum GGT and other outcome variables were
established using Pearson correlation coefficients in the higher AUDIT group. Results: No
significant differences were found between lower and higher AUDIT groups with respect to
average (± SD) VO2max (62.37 ± 11.09 vs. 62.02 ± 5.16 ml/kg FFM/min), average MVPA (45.15
± 23.55 vs. 49.99 ± 16.82 minutes/day), body fat % (26.7 ± 8.0 vs. 22.9 ± 4.1 %) and serum
GGT (13.93 ± 1.96 vs. 15.94 ± 3.33 U/L). For the higher AUDIT group, there was no correlation
between serum GGT and VO2max or body fat %, but there was a trend towards a negative
correlation between average daily MVPA and serum GGT (r = -0.65, p = 0.06). Conclusion:
Findings suggest that chronic physical activity has a positive impact on serum GGT in
individuals with high AUDIT scores. These findings warrant further investigation with larger
sample size.
Keywords: Serum GGT, exercise and liver health, gamma-glutamyltransferase, physical activity
and serum GGT, cardiorespiratory fitness.
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Chapter I
Introduction
Serum Gamma-Glutamyltransferase (GGT) and Alcohol Ingestion. Gammaglutamyltransferase (GGT) is a liver enzyme associated with neutralizing oxidative stress via the
mediation of peptide transport and glutathione metabolism. Elevated GGT levels can indicate
liver damage and disease due to the increased release or synthesis of GGT from damaged liver
cells 1. Serum GGT levels to be elevated up to 10 times the normal levels in alcoholics due to the
attenuated clearance of GGT when alcohol-induced liver damage is present 2,3. There is also a
positive relationship between alcohol intake and serum GGT among individuals who do not have
alcoholism. In a study by Alatalo et al., liver enzymes of alcohol-abstaining subjects and
moderate drinkers were assessed, revealing elevated GGT levels in moderate drinkers in
comparison to alcohol abstainers 4. Sharp et al. found similar results in patients at an alcohol and
drug abuse hospital. GGT levels were elevated significantly in all groups that consumed alcohol,
even those who only drank socially 5. Therefore, it appears that alcohol consumption of any kind
is associated with liver damage as indicated by elevated serum GGT.
College Students and Alcohol Ingestion. Among college-aged individuals in America, repeated
binge-drinking and above moderate intake of alcohol is prevalent. Knight et al. describe
binge/heavy episodic drinking as having five or more drinks in a single occasion for men and
four or more drinks in a single occasion for women (in the two weeks prior to measurement).
After evaluating a large population of college students, Knight et al. found that 80.9% of
students consumed alcohol of any amount and only 19.1% abstained. Of those who consumed
alcohol, 21.5% were described as occasional heavy episodic drinkers and 22.7% were described
as frequent episodic drinkers 6. According to a national survey by Johnson et al. in 2015, 32% of
6

college students reported having five or more drinks in one sitting on one or more occasions in
the two weeks prior to survey and 13.0% of college students reported having 10 or more drinks
in one sitting on one or more occasions in the two weeks prior to survey 7. These drinking habits
can result in liver damage as indicated by elevated liver enzymes such as GGT.
Other Causes of Serum GGT Elevation. In addition to liver damage and alcohol consumption,
high serum GGT levels have also been associated with pancreatic disease, biliary disease, and
the intake of drugs such as cocaine, antibiotics and anabolic steroids. In a study by Lee et al.,
GGT levels above 40 U/L were found to be tightly linked to incidence of type II diabetes,
especially in diabetic subjects between 45 and 55 years old and those with a BMI between 27
and 32 kg/m2 8. These potential contributors to serum GGT elevation are not expected in a
healthy, college-aged population.
Serum GGT levels may also be elevated in the presence of several cardiovascular disease
risk factors including smoking, older age, sedentary lifestyle, high BMI, and high blood
pressure8. Celik et al. found that serum GGT in alcohol-abstaining young adults with prehypertension was positively associated with decreased arterial elasticity, a contributing factor to
hypertension. These findings suggest that serum GGT contributes to hypertension independently,
but is not elevated due to hypertension 9.
Blood lipid levels (HDL and LDL) are also with GGT levels. Patel et al. discovered that
young adults with persistently high GGT levels had significantly higher average LDL levels and
significantly lower HDL levels than subjects with low GGT levels 10. The relationship between
serum GGT and LDL levels also seems to contribute to atherosclerosis. Paolicchi et al. studied
the blood lipid and liver enzyme levels in patients with coronary atherosclerosis and found that
the amount of GGT bound to LDL was directly proportional to serum GGT levels in all subjects,
7

regardless of alcohol intake. The complex that forms when GGT binds LDL contributes to LDL
oxidation, causing damage to the arterial wall. This damage results in plaque build-up in the
arteries, ultimately contributing to atherosclerosis 11. Based on Paolicchi et al.’s findings, it
appears that GGT is also independently related to increased LDL oxidation and atherosclerosis.
Exercise Training and Serum GGT. Considering exercise has antioxidant effects, it is possible
that habitual training might affect liver health as indicated by altered serum GGT levels. Little
research has been conducted on the effects of exercise training on liver health and serum GGT
levels in human subjects with liver disease; however, results from a recent study by Linden et al.
found that the increased mitochondrial content in the liver associated with high aerobic fitness
protected against liver damage in aerobically fit rats. Additionally, Linden et al. found that
aerobically fit rats that had continuous access to ethanol over 8 weeks were resistant to liver
damage. The findings suggest that aerobic training protects against alcohol-induced liver damage
in rats due to direct increases in mitochondrial health and decreases in mitochondrial betaoxidation, ultimately leading to improved liver function, decreased apoptosis, increased antiapoptosis processes, and decreased inflammation 12. The present study aims to investigate the
presence of the protective effects of fitness among humans who consume alcohol.
Summary. In conclusion, elevated serum GGT levels are associated with the intake of alcohol
and liver damage. Elevated serum GGT levels can also be caused by pancreatic disease, type II
diabetes, cocaine use, anabolic steroid use, biliary disease, and antibiotic intake. Serum GGT
levels are associated with many risk factors of cardiovascular disease and have been found to be
independently associated with oxidized LDL and hypertension. Alcohol use, specifically bingedrinking, appears to be prevalent among college-aged individuals and can cause liver damage. It
is not yet known whether fitness levels and/or chronic physical activity levels influences liver
8

function in college-aged individuals who consume alcohol, but high aerobic capacity has been
shown to improve liver function and protect against alcohol-induced liver damage in rats. The
present cross-sectional study aims to evaluate whether serum GGT levels are affected by body
composition, cardiorespiratory fitness, and/or physical activity in college-aged individuals who
drink alcohol. We hypothesize that serum GGT levels will be positively associated with alcohol
intake and body fat percentage and negatively associated with chronic physical activity levels
and cardiorespiratory fitness.
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Chapter II
Methods
Subjects. College-aged subjects from James Madison University will be studied. All subjects
will be 21 years old or older and self-report consuming at least four drinks per month. All
subjects will complete the Alcohol Use Disorders Identification (AUDIT) to assess alcohol
intake and drinking related behavior, which has been validated in college students 13. A copy of
this survey is included in Appendix B. The World Health Organization has noted an AUDIT
score of eight or more as indicative of hazardous and harmful alcohol use 14. Therefore, we will
subdivide our sample into subjects with lower (AUDIT > 8) and higher (AUDIT < 8) scores.
Informed consent will be given to each subject prior to data collection (Appendix A).
Physical Activity Assessment. To determine the subjects’ physical activity levels, each
participant will wear an Actigraph accelerometer around the hip for seven days and will be
removed during showering and sleeping. For inclusion of the data, the accelerometer has to
record at least 10 hours of data on at least four of the seven days. From the valid days, the
average minutes per day spent in moderate-to-vigorous physical activity (MVPA) will be
obtained. The use of an accelerometer to determine the physical activity levels of college
students has been validated previously in the literature 15.
Cardiorespiratory Fitness. The cardiorespiratory fitness of all subjects will be evaluated during
a graded exercise test to volitional exhaustion on a treadmill to evaluate maximum oxygen
consumption (VO2max). The test will begin at 3.0 mph and will increase by 0.5 mph each minute
until 6.0 mph is reached. After this point, grade will increase by 3% per minute until volitional
exhaustion. Oxygen uptake (VO2) will be continuously assessed using a Sensormedics (Yorba
Linda, CA) metabolic cart. VO2max will be defined as the largest 30-second average in VO2 that
10

was achieved during the test. To ensure that a true VO2max is achieved, a verification stage will
be implemented at the end of the test. After 5 minutes of walking subjects will begin the test
again at the speed and grade that immediately preceded their final stage and will continue until
volitional fatigue.
Body Composition. Height will be determined using a stadiometer and weight and body fat
percentage will be determined using a Lunar (GE Healthcare, Chicago IL) dual energy x-ray
absorptiometry (DEXA) machine. All subjects will have a full body scan performed.
Serum GGT Assessment. To determine the subjects’ serum GGT levels, venous blood draws
will be obtained the morning following a 10-hour fast. Water consumption will be allowed
during the fast. Blood will be drawn from an antecubital vein into a 10 mL Vacutainer (Becton
Dickenson, Franklin Lakes, NJ) serum blood collection tube and will be allowed to clot for 30
minutes. The blood sample will then be centrifuged at 2000 x g for 10 minutes in a refrigerated
centrifuge. The resulting serum will be stored at −80℃ until analysis. Serum GGT will be
assayed in duplicate using a commercially available colorimetric assay (Sigma-Aldrich, St.
Louis, MO).
Statistical Analysis. To minimize gender differences, VO2max will be expressed relative to lean
body mass (ml/kg ffm/min). Body fat %, VO2max (ml/kg FFM/min), Average MVPA, and serum
GGT will be compared between low and high AUDIT groups using an independent t-test. For the
higher AUDIT group, Pearson correlation coefficients will be used to establish the association
between serum GGT and: Body fat %, VO2max, and average MVPA. A priori statistical
significance will be set at P <0.05.
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Chapter III
Manuscript
Introduction
Gamma-glutamyltransferase (GGT) is a hepatic enzyme associated with neutralizing
oxidative stress via the mediation of peptide transport and glutathione metabolism. Elevated
GGT levels can indicate liver damage and disease due to the increased release or synthesis of
GGT from damaged liver cells 1. Elevated serum GGT levels have been observed in individuals
who drink alcohol in any amount including social drinkers, moderate drinkers, heavy drinkers,
and alcoholics 2–4. Among college-aged individuals in the US, repeated binge-drinking and above
moderate intake of alcohol is prevalent. Studies suggest that over 80% of college students
consume alcohol, and many engage in occasional heavy drinking or frequent heavy drinking 5,6.
Such drinking habits may result in liver damage as indicated by elevated liver enzymes such as
serum GGT.
Because chronic exercise has antioxidant properties, it is possible that habitual training
status might affect liver health as indicated by lowered serum GGT levels. A previous study
concluded that the increased mitochondrial content in the liver associated with high aerobic
fitness protected against liver damage in rats treated with ethanol7. This suggests that aerobic
training protects against alcohol-induced liver damage in rats due to direct increases in
mitochondrial health and decreases in mitochondrial beta-oxidation, ultimately leading to
improved liver function, decreased apoptosis, increased anti-apoptosis processes, and decreased
inflammation; however, this possibility has not been evaluated in humans. The present study
evaluated whether serum GGT levels are affected by body composition, cardiorespiratory fitness,
and/or physical activity in college-aged individuals who drink alcohol.
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Methods
Participants. Sixteen healthy, college-aged subjects from James Madison University (seven
males and nine females) were studied. All subjects were 21 years old or over and self-reported
consuming at least four drinks per month. All subjects completed the Alcohol Use Disorders
Identification (AUDIT) to assess alcohol intake and drinking related behavior, which has been
validated in college students 8. A copy of this survey is included in Appendix B. The World
Health Organization has noted an AUDIT score of eight or more as indicative of hazardous and
harmful alcohol use 9. Therefore, we subdivided our sample into subjects with lower [AUDIT >
8 (n = 7)] and higher [AUDIT < 8 (n = 9)] scores. Descriptive characteristics for both groups are
shown in table 1. A copy of the informed consent given to each subject prior to data collection is
located in Appendix A.
Body Composition. Height was determined using a stadiometer and weight and body fat
percentage was determined using a Lunar (GE Healthcare, Chicago IL) dual energy x-ray
absorptiometry (DEXA) machine.
Cardiorespiratory Fitness. The cardiorespiratory fitness of all subjects was evaluated during a
graded exercise test to volitional exhaustion on a treadmill to evaluate maximum oxygen
consumption (VO2max). The test began at 3.0 mph and was increased by 0.5 mph each minute
until 6.0 mph was reached. After this point, grade was increased by 3% per minute until
volitional exhaustion. To ensure that a true VO2max was achieved, a verification stage was
implemented at the end of the test. After 5 minutes of walking on the treadmill at 3.0 mph,
subjects began the test again at the speed and grade that immediately preceded their final stage
and continued until volitional fatigue. Oxygen uptake (VO2) was continuously assessed using a
CareFusion Vmax Encore (Yorba Linda, CA) metabolic cart. VO2max was defined as the largest
13

30-second average in VO2 that was achieved during the test.
Physical Activity Assessment. To determine the subjects’ physical activity levels, each
participant wore an Actigraph accelerometer around the hip for seven days. The accelerometer
was only removed during showering and sleeping. For inclusion of the data, the accelerometer
had to record at least 10 hours of data on at least four of the seven days. From the valid days, the
average minutes per day spent in moderate-to-vigorous physical activity (MVPA) was obtained.
The use of an accelerometer to determine the physical activity levels of college students has been
validated in previous literature 10.
Serum GGT Assessment. To determine the subjects’ serum GGT levels, venous blood draws
were obtained the morning following a 10-hour fast. Blood was drawn from an antecubital vein
into a 10 mL Vacutainer (Becton Dickenson, Franklin Lakes, NJ) serum blood collection tube
and was allowed to clot for 30 minutes. The blood samples were then centrifuged at 2000 x g for
10 minutes in a refrigerated centrifuge. The resulting serum was stored at −80℃ until analysis.
Serum GGT was assayed in duplicate using a commercially available colorimetric assay
(Biomatik, Wilmington, DE).
Statistical Analysis. To minimize gender differences, VO2max was expressed relative to lean
body mass (ml/kg ffm/min). Body fat %, VO2max (ml/kg FFM/min), Average MVPA, and serum
GGT were compared between alcohol intake groups using an independent t-test. For the higher
AUDIT group, Pearson correlation coefficients were used to establish the association between
serum GGT and: Body fat %, VO2max, and average MVPA. A priori statistical significance was
set at P <0.05.
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Results
There were no significant differences between the higher and lower AUDIT groups with
respect to serum GGT, body fat %, VO2max, and MVPA, as shown in Table 2. Within the higher
AUDIT group, there was no significant relationship between VO2max and serum GGT (r = -0.38,
p = 0.31) or body fat % and serum GGT (r = -0.52, p = 0.16). There was a trend towards a
correlation between average daily MVPA and serum GGT (r = -0.65, p = 0.06, Figure 1).
Discussion
In the present study, serum GGT levels in the lower and higher AUDIT groups were not
significantly different. The serum GGT levels in both the lower and higher AUDIT group
reflected female serum GGT levels in the 50th to the 75th percentile and male serum GGT levels
in the 25th to the 50th percentiles 11. The similar GGT levels between groups conflicts with
findings from Sharp et al. and Alatalo et al. in which serum GGT was positively associated with
alcohol intake 3,4.
It is possible that the similarities in serum GGT between the AUDIT groups were the
result of similar body fat % between the two groups. A study by Jong Choi in which the serum
activities of several liver enzymes were measured from 732 subjects found that the serum GGT
levels in both men and women with high fatness were significantly higher than those with low
fatness 12. Because the body fat percentages of the two AUDIT groups in the present study were
not significantly different, this could have driven the similar serum GGT values observed
between the two groups. Additionally, the VO2max levels between the two groups were not
different. Devries et al. evaluated VO2peak and serum GGT levels of 20 obese and 21 lean men
and women before and after 12 weeks of endurance training. VO2peak and serum GGT in the lean
and obese male groups were significantly increased and decreased respectively after training and
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these effects were independent of weight loss 13. The subjects used for the present study all had
relatively high VO2max values, regardless of alcohol intake. Thus, it is possible that the high
fitness levels in the high AUDIT group were protective against elevated serum GGT levels.
Correlation between serum GGT and fitness related variables was confined to the higher
AUDIT group to isolate the effects of fitness in individuals with potentially harmful/hazardous
drinking habits. We observed no correlation within the high AUDIT group between serum GGT
and body fat % or VO2max. There was a negative (though not significant) correlation (p = 0.06)
between serum GGT and MVPA which suggests that chronic physical activity levels may
combat some of the negative effects of alcohol on the liver independent of having high
cardiorespiratory fitness; however, further study is needed to fully examine this relationship. A
post-hoc sample size calculation revealed that 16 subjects in the higher AUDIT group would be
necessary to obtain statistical significance.
One limitation of the present study was that the two alcohol intake groups were
imbalanced with respect to gender. Previous literature has shown that the baseline serum GGT
levels of men and women are different such that a gender effect should be examined in this
context 11. Future studies should use a large enough sample to capture gender effects. It is likely
that having more males and fewer females in the lower and higher AUDIT groups, respectively,
would increase serum GGT in the former and decrease serum GGT in the later. This would tend
to make our groups even more similar with respect to serum GGT. This is the first known study
to evaluate the effects of fitness related variables on serum GGT. Future cross-sectional studies
comparing active and inactive groups would also help elucidate the potential effects of chronic
physical activity and physical fitness. Finally, longitudinal training studies should be done to
elucidate the role of activity and/or cardiorespiratory fitness on serum GGT.
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In conclusion, in the present study, there were no differences found in serum GGT, %
body fat, VO2max, and average MVPA between the high and low AUDIT groups. There was a
trend towards a correlation between serum GGT and average MVPA within the high AUDIT
group that encourages more data collection for this project.
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Table 1. Mean ± SD of age, height, weight, and ratio of males to females in the lower (n = 7) and
higher (n = 9) AUDIT groups.
AUDIT < 8
AUDIT > 8
Age

21.29 ± 0.18

21.65 ± 0.242

Height (cm)

162.81 ± 3.44

172.88 ± 3.08

Weight (kg)

64.43 ± 3.31

74.45 ± 3.96

2/5

5/4

Males/Females

Table 2. Mean ± SD of serum GGT, body fat %, VO2max, and average moderate-to-vigorous
physical activity (MVPA) for the lower and higher AUDIT score groups.
AUDIT < 8
AUDIT > 8
Serum GGT (U/L)

13.93 ± 1.96

15.94 ± 3.33

Body Fat (%)

26.70 ± 7.96

22.86 ± 4.05

VO2max (mL/kgFFM/min)

62.37 ± 11.09

62.02 ± 5.16

MVPA (mins/day)

45.15 ± 23.55

49.99 ± 16.82
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Serum GGT (U/L)
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Figure 1. Relationship between average MVPA per day and serum GGT in individuals with an
AUDIT score > 8. (r = -0.65, p =0.06)
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Appendix A
Informed Consent Form
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Consent to Participate in Research
Identification of Investigators & Purpose of Study
You are being asked to participate in a research study conducted by Gillian Mackey, Jessica Irons, Danielle Valenti
and Chris Womack from James Madison University. The purpose of this study is to determine is physical activity
and/or physical fitness impacts early signs of liver damage from alcohol consumption. This study will contribute to
completion of Gillian Mackey’s Honors Thesis.

Research Procedures
Should you decide to participate in this research study, you will be asked to sign this consent form once all your
questions have been answered to your satisfaction. In addition, you will be asked to complete a health history
questionnaire that includes your known history of disease, medical procedures, and medications. This study consists
of two visits to the Human Performance Laboratory in Godwin Hall, Room 209. For the first visit, you will
complete a survey that allows us to obtain information on your alcohol intake. Additionally, you will perform a
treadmill test that allows us to determine the maximal amount of oxygen that your body is capable of using
(VO2max). This is a good evaluation of your cardiovascular system’s ability to supply blood to your working
muscles. For this visit, you will be asked to refrain from eating or drinking anything except water for three hours
prior to the test. Following your first visit, you will receive a physical activity tracking device that you will wear
over a seven-day period. You will be given access to $10 if you wear the device (as evidenced by our electronic data
collection) 80% (or more) of the time during this seven-day period. In addition, once you return the device you will
be entered into a drawing to win a $100 prize. You will return it to the laboratory one week later for your second
visit, which will involve assessment of your body fat percentage and a blood draw. For this visit, you will be asked
to refrain from eating or drinking anything except water for 10 hours prior to reporting to the lab. You will also be
asked to refrain from consuming alcoholic beverages for 24 hours prior to reporting.
VO2max Test (1st visit): To determine your cardiorespiratory endurance, you will begin walking on a treadmill at 2.5
miles/hour. The speed of the treadmill will increase every minute until you reach 6.0 miles/hour. After that, the
elevation (grade) of the treadmill will increase by 3% per minute until you indicate that you can no longer continue.
After a 5-minute rest, you will resume the test at the intensity that preceded your highest intensity achieved during
the test. We will continue the test in the same manner until you indicate that you can no longer continue.
Throughout the test, you will be breathing through a mouthpiece so that we can collect and analyze your expired air
for oxygen content. You will also wear a strap around your chest so that we can monitor your heart rate.
DEXA Scan (2nd visit): Your body fat percentage will be determined by a dual-energy x-ray absorptiometry
(DEXA) scan. This will involve lying on a cushioned table while the machine scans your entire body with a lowlevel x-ray.
Blood Draw (2nd visit): After sitting in a chair for 15 minutes, we will obtain blood samples from an arm vein. A
total of 15 ml (about 1 tablespoon) of blood will be collected. These blood samples will be used to assess levels of a
marker of liver damage, your blood lipid and cholesterol levels and markers of your blood’s tendency to clot.

Time Required
Your participation will require two sessions over the course of a week. It is estimated that each session will take
about 45 minutes each for a total of 90 minutes for the entire study.

Potential Risks
The investigator perceives the following are possible risks arising from your involvement with this study. Venous
blood draws involve the risk of pain, bruising and, in rare instances, infection. All of our investigators that draw
blood for our research studies are trained to minimize these risks. Research on risk of exercise testing has suggested
that approximately six cardiac events occur for every 10,000 exercise tests. The risk of death is even less, with a
rate of approximately one death per 1,000,000 tests. This is likely to be even less in college-aged individuals. In the
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unlikely event of an event, at least one investigator will be CPR-trained at every test. The DEXA test involves
exposure to low-level radiation. This exposure is approximately the same as the exposure from a flight across the
United States.

Potential Benefits
Potential benefits from participation in this study include feedback on your current level of cardiorespiratory fitness
and body composition. In addition to your actual scores, you will be given established norms for both fitness-related
variables. The overall benefit of the study may include furthering knowledge about how physical activity and
physical fitness may impact the effects of alcohol. Participants enrolled in PSYC 101 or PSYC 160 at the time of
participation will receive 3-credit hours for participation that will be allocated via the Psychology Participant Pool
(Sona Systems). You will also have the opportunity to earn $10 for wearing an activity device for 7 days as
instructed and included in a drawing to win an additional $100 prize. The exact odds of winning the $100 prize are
unknown until we know how many participants enroll in our study; however, participants will only be entered into
the drawing ONCE if they wear the device for 80% (or more) of the time as instructed AND return the device as
requested.

Confidentiality
The results of this research will be presented at relevant regional and national/international conferences. Our
findings will also be published in relevant research journals and/or books in the field of exercise science. The
results of this project will be coded in such a way that your identity will not be attached to the final form of this
study. The researcher retains the right to use and publish non-identifiable data. While individual responses are
confidential, aggregate data will be presented representing averages or generalizations about the responses as a
whole. All data will be stored in a secure location accessible only to the researcher. Upon completion of the study,
all information that matches up individual respondents with their answers will be destroyed.

Participation & Withdrawal
Your participation is entirely voluntary. You are free to choose not to participate. Should you choose to participate,
you can withdraw at any time without consequences of any kind.

Questions about the Study
If you have questions or concerns during the time of your participation in this study, or after its completion or you
would like to receive a copy of the final aggregate results of this study, please contact:
Gillian Mackey
Department of Kinesiology
James Madison University
mackeygo@dukes.jmu.edu

Christopher Womack
Department of Kinesiology
James Madison University
Telephone: (540) 568-6515
womackcx@jmu.edu

Questions about Your Rights as a Research Subject
Dr. David Cockley
Chair, Institutional Review Board
James Madison University
(540) 568-2834
cocklede@jmu.edu
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Giving of Consent
I have read this consent form and I understand what is being requested of me as a participant in this study. I freely
consent to participate. I have been given satisfactory answers to my questions. The investigator provided me with a
copy of this form. I certify that I am at least 18 years of age.
______________________________________
Name of Participant (Printed)
______________________________________ ______________
Name of Participant (Signed)
Date
______________________________________ ______________
Name of Researcher (Signed)
Date
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Appendix B
Alcohol Use Disorders Identification Test (AUDIT)
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Alcohol Use Disorders Identification Test (AUDIT)
1. How often do you have a drink containing alcohol?
2. How many drinks containing alcohol do you have on a typical day when you are
drinking?
3.

How often do you have six or more drinks on one occasion?

4.

How often during the last year have you found that you were not able to stop drinking
once you had started?

5.

How often during the last year have you failed to do what was normally expected from
you because of drinking?

6.

How often during the last year have you needed a first drink in the morning to get
yourself going after a heavy drinking session?

7. How often during the last year have you had a feeling of guilt or remorse after drinking?
8. How often during the last year have you been unable to remember what happened the
night before because you had been drinking?
9. Have you or someone else been injured as a result of your drinking?
10. Has a relative or friend or a doctor or another health worker been concerned about your
drinking or suggested you cut down?
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Appendix C
VO2max Data Sheet
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Subject #-

Temp-

Date-

Rh-

Height (cm)-

Pb-

Weight (kg)-

Region %Fat-

BMD t-score-

AgeTime
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15

Speed (mph)
3.0
3.5
4.0
4.5
5.0
5.5
6.0
6.0
6.0
6.0
6.0
6.0
6.0
6.0
6.0

Elevation (%)
0
0
0
0
0
0
0
3
6
9
12
15
18
21
24

HR

RPE

Exercise test duration:
Difference between VO2 in last 2 full stages:
Validation Stage
Time

Speed

Elevation

VO2

Validation Stage duration:
VO2max from validation stage? (Y/N):
MAX HR

MAX VO2 (L/min) MAX RQ
28

MAX RPE

VO2 (L/min)
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